These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 30265714

  • 21. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
    Jiang T, Cheng W, Yao Y, Tan H, Wu K, Li J.
    Malar J; 2020 Nov 25; 19(1):434. PubMed ID: 33238987
    [Abstract] [Full Text] [Related]

  • 22. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK, Kassa M, Kebede A, Mohammed H, Leta GT, Woyessa A, Guma GT, Petros B.
    PLoS One; 2015 Nov 25; 10(10):e0126943. PubMed ID: 26431464
    [Abstract] [Full Text] [Related]

  • 23. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
    Myers-Hansen JL, Abuaku B, Oyebola MK, Mensah BA, Ahorlu C, Wilson MD, Awandare G, Koram KA, Ngwa AA, Ghansah A.
    PLoS One; 2020 Nov 25; 15(12):e0233478. PubMed ID: 33284800
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
    Ogouyèmi-Hounto A, Ndam NT, Kinde Gazard D, d'Almeida S, Koussihoude L, Ollo E, Azagnandji C, Bello M, Chippaux JP, Massougbodji A.
    Malar J; 2013 May 01; 12():147. PubMed ID: 23634705
    [Abstract] [Full Text] [Related]

  • 25. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
    Lucchi NW, Okoth SA, Komino F, Onyona P, Goldman IF, Ljolje D, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S.
    Antimicrob Agents Chemother; 2015 Jul 01; 59(7):3995-4002. PubMed ID: 25896703
    [Abstract] [Full Text] [Related]

  • 26. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
    Malar J; 2008 Jul 01; 7():115. PubMed ID: 18590577
    [Abstract] [Full Text] [Related]

  • 27. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
    Ogouyèmi-Hounto A, Ndam NT, Fadégnon G, Azagnandji C, Bello M, Moussiliou A, Chippaux JP, Kinde Gazard D, Massougbodji A.
    Malar J; 2013 Nov 13; 12():413. PubMed ID: 24225351
    [Abstract] [Full Text] [Related]

  • 28. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
    Kayode AT, Ajogbasile FV, Akano K, Uwanibe JN, Oluniyi PE, Eromon PJ, Folarin OA, Sowunmi A, Wirth DF, Happi CT.
    Sci Rep; 2021 Jan 12; 11(1):471. PubMed ID: 33436791
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
    Gikunju SW, Agola EL, Ondondo RO, Kinyua J, Kimani F, LaBeaud AD, Malhotra I, King C, Thiong'o K, Mutuku F.
    Malar J; 2020 May 24; 19(1):190. PubMed ID: 32448228
    [Abstract] [Full Text] [Related]

  • 30. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
    Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A.
    Malar J; 2017 Jan 13; 16(1):28. PubMed ID: 28086777
    [Abstract] [Full Text] [Related]

  • 31. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
    Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, Guérin PJ, Fandeur T, Sibley CH.
    Malar J; 2018 Feb 27; 17(1):98. PubMed ID: 29486766
    [Abstract] [Full Text] [Related]

  • 32. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
    Lumb V, Das MK, Singh N, Dev V, Wajihullah, Sharma YD.
    Antimicrob Agents Chemother; 2009 Dec 27; 53(12):5173-80. PubMed ID: 19786603
    [Abstract] [Full Text] [Related]

  • 33. Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.
    Basuki S, Fitriah, Riyanto S, Budiono, Dachlan YP, Uemura H.
    Malar J; 2014 Apr 04; 13():135. PubMed ID: 25187019
    [Abstract] [Full Text] [Related]

  • 34. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
    Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA.
    Malar J; 2014 Apr 21; 13():152. PubMed ID: 24751352
    [Abstract] [Full Text] [Related]

  • 35. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ, Mahdy MAK, Lau YL, Fong MY, Abdul-Ghani R, Mahmud R.
    Acta Trop; 2016 Oct 21; 162():174-179. PubMed ID: 27343362
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of mutation in the Plasmodium falciparum dhfr and dhps genes in field isolates from Sabah, Northern Borneo.
    Abdullah NR, Norahmad NA, Jelip J, Sulaiman LH, Mohd Sidek H, Ismail Z, Noedl H.
    Malar J; 2013 Jun 12; 12():198. PubMed ID: 23758930
    [Abstract] [Full Text] [Related]

  • 37. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R, Khan N, Sandeepta S, Pati S, Das A, Bal M, Ranjit M.
    Malar J; 2022 Dec 24; 21(1):394. PubMed ID: 36566182
    [Abstract] [Full Text] [Related]

  • 38. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
    Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P.
    Malar J; 2011 Jul 19; 10():196. PubMed ID: 21767415
    [Abstract] [Full Text] [Related]

  • 39. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
    Amenga-Etego LN, Asoala V, Agongo G, Jacob C, Goncalves S, Awandare GA, Rockett KA, Kwiatkowski D.
    Malar J; 2021 Mar 17; 20(1):152. PubMed ID: 33731134
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec 17; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.